Summary | Valeant Pharmaceuticals International Inc. could have
trouble getting a clean opinion from auditors on its 2015
financial statements, according to accounting experts. That
could complicate negotiations with bank lenders, who could
force the company into default if auditors don't sign off on
the 2015 finances. ...
blogs.wsj.com | 21 March 2016